Crestor showed decrease in prescription cost because of keen competition between 47 generics

On June 18, according to the data of Ubist, Crestor recorded prescription cost of 6.3 billion won in May, which is decreased by 13% compared to the prescription cost of 7.2 billion won in April.

The reason why Crestor showed decrease in prescription cost is keen competition between 47 generics which were launched after April 10.

These generics recorded prescription cost of 4.1 billion won in ...